Pharmacology Flashcards
drugs causing hepatitis/necrosis (increased ALT)
dose dependent
paracetamol OD
ADA
dose independent
drugs causing hepatitis/necrosis (increased ALT)
- isoniazid, pyrazinamide
- valproate
- Methyldopa
- NSAIDs
- Phenytoin
- statins
Drugs causing Cholestasis (ALP + Bi)
Dose dependent
- Rifampicin
* Oestrogens + anabolic steroids (pure cholestasis)
Drugs causing Cholestasis (ALP + Bi)
Dose INdependent
•chlorpromazine •clarythromycin •clavulanate-amox •cloxacillin flu- •chlorpropamide •carbimazole •cimetidine Often associated hepatitis Impaired bile excretion from hepatocellular canaliculus (no obstruction in bile duct)
statosis (-hepatitis) = fatty liver
caused by
Microvesicular fat: ‘VAT’ = Reye’s syndrome, Mitochondria, β-oxidation •Valproate •Aspirin •Tetracyclines Macrovesicular fat - and cirrhosis; Triglyceride accumulation •Alcoholic hepatitis •Amiodarone •Methotrexate
ADRs time dependent: RAPID
examples and implication
red man sydrome with iv vancomycin
|»_space; administer slowly
ADR First dose example
hypotension with ACEi
type 1 hypersesnsitivity ADR example
penicilling
intermediate time (risk increases at first, then diminishes: examples
Agranulocytosis (carbimazole, 5-ASA’s) - first 3/12
|»_space;> warn patient to report sore throat
late time ADR (risk increases with time
examples
osteoporosis with corticosteroids
tardive dyskinesia with dopamine
pharmacokinetics is
:“What the body does to drugs”
•Absorption •Distribution •Metabolism •Excretion
pharmacodynamics is
what the drug does to the body
interactions PK - absorbtion
•GI motility
–opioids/antimuscarinic: TCA↓; metoclopromide↑
•Absorption: –cholestyramine – ↓ digoxin, warfarin
•Chelation
–by antacids (Al, Mg, Ca) + milk of tetracyclines, iron + prednisolone
•Gut flora –
–antibiotics ↓ vit. K synthesis – potentiate warfarin
Interactions: PK - Metabolic Liver enzyme inducers:
• Phenytoin PC BRAS` • Carbamazepine • Barbiturates & BBQ’d foods • Rifampicin • Alcohol - chronic • Smoking, St. Johns Wort, Sulphinpyrazone (→theophylline)
PK interactions: Displacement
• Displaced drug metabolized & excreted
– usually need 2nd mechanism to be clinically significant, e.g.:
• Displacement from plasma proteins
– Valproate displaces phenytoin & inhibit metab.
– ASA + NSAIDs displace methotrexate & ↓ secretion → serious MTX toxicity
– Sulponamides, vit. K + indometacin displace bilirubin & immature metabolism in neonate →kernicterus
• Displacement from tissue binding
– Amiodarone displaces digoxin & impairs its excretion
Interactions: PK - Metabolic Liver enzyme inhibitors
GO DEVICES
- Grapefruit juice
- Omeprazole
- Disulfiram
- Erythromycin
- Valproate
- Isoniazid
- Cimetidine
- Ethanol (acute)
- Sulphonamides
Allopurinol Metronidazole, ketoconazole Ciprofloxacin Verapamil + diltiazem Amiodarone Chloramphenicol SSRIs Sulphinpyrazone (→warfarin,phenytoin)
Interactions: PK – Metabolic; Clinically significant if narrow therapeutic range:
WAC STOPS •Warfarin •Anti arrhythmics •Ciclosporin •Sulphonylureas •Theophyllines •Oral Contraceptive Pill •Phenytoin •Steroids, statins
Statins & CYP3A4 inhibitors
- Risk of rhabdomyolysis, myositis, myopathy
- Especially simvastatin
- Caution atorvastatin
- Fluvastatin CYP2C9
- Pravastatin & rosuvastatin minimal CYP metab
Interactions: PK - Warfarin
- protein binding displacement (99%)
- salicylates/ NSAIDs, sulphonamides
- inhibit metabolism
- amiodarone, metronidazole, sulhinpyrazone, acute alcohol, cimetidine
- induction of metabolism: ‘PC BRAS’’
- Cranberry juice:↑INR/bleeding
- Care with statins
Extramicrosomal inhibitor interactions
Precipitant Enzyme Object
allopurinol xanthine oxidase azathioprine
carbidopa dopa decarboxylase L-dopa
metronidazole aldehyde dehydrogenase alcohol
MAOIs MAO tyramine, amphetamine
Interactions: PK - Excretion
Glomerular filtration (unbound drug only)
•Active tubular secretion
–also ↓ in renal failure
–penicillin inhibited by probenicid
–digoxin inhibited by amiodarone (MDR1) + CCBs
–MTX inhibited by salicylates – serious toxicity
–Uricosuric/uricostatic agents
•Passive tubular reabsorption
–weak acids (aspirin) inhibited in alkaline urine (more ionized )
–lithium ↑with Na depletion due to diuretics
Penicillin: probenicid Nifedipine: digoxin Digoxin: verapamil Aspirin: methotrexate Sodium bicarb: aspirin Denrofluazide: lithium
Interactions: PD
•Actions on receptors
•Antagonistic: naloxone for morphine OD, B blockers and salbutamol
•Actions on body systems
•Antagonistic: NSAIDs and diuretics/ BB’s
•Synergistic: iv verapamil & BB – asystole
–theophylline & B agonists – arrhythmias
–loop diuretic & aminoglycoside – both ototoxic
–Sedation with amitrityline + diazepam
–Aspirin & streptokinase
Interactions: Adenosine
- Dipyridamole – potentiates effect of adenosine +++
- If essential to give adenosine, reduce initial dose to 0.5-1 mg.
- Mechanism –Reversibly inhibits plt phosphodiesterase
- ↑cAMP →↓plt thrombotic activity
- Dipyridamole blocks adenosine uptake - increases adenosine levels
- leading to inhibition of platelet aggregation and vasodilatation mainly in the coronary tree
- Theophylline/caffeine – inhibit phosphodiesterase attenuate effects of adenosine
Naloxone:morphine Atenolol: slabutamol Ibuprofen: bedroflumathiazide Atenolol: IV verapamil stat Frusemide: digoxin (hypokalaemia)
Theophyline: salbutamol
Frusemide: gentamycin
Amitryptyline: diazepam
Aspirin: iboprufen
Risks: Necessary prophylaxis exampels
- ASA/NSAIDs: Hx bleeding, on anticoagulant, combination, Or 2 of: >60 y, corticosteroids, GORD; PPIs, e.g. lansoprazole
- Opioids: Laxatives
- corticosteroids: bone –if likely to take ≥7.5 mg pred - 3 months; eg. bisphosphonates – alendronate